Acquiring a MIS Market Position
Rumor has it Enovis is acquiring Novastep from Amplitude Surgical SAS, a public company listed on the Paris stock exchange. The gold nuggets for Enovis in the Novastep portfolio are the MIS portfolio and Fusionframe external fixation.
Novastep MIS portfolio?
MIS is a rapidly growing sector of the foot and ankle space and Novastep has a solid position. First launched in 2019, PECA implant systems for MIS bunion cuts and fixation underwent updates in 2021 with the launch of a guided instrumentation and implant platform PecaPlasty for percutaneous bunion correction.
Enovis is a player
With sales of $1.4 billion and growing at a robust 27.3%, annually, Enovis is ranked 6th among the largest orthopedic companies. Watch for its continued push in the foot and ankle space.